Expression of Podocyte-Associated Molecules in Acquired Human Kidney Diseases
Top Cited Papers
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (8) , 2063-2071
- https://doi.org/10.1097/01.asn.0000078803.53165.c9
Abstract
Proteinuria is a poorly understood feature of many acquired renal diseases. Recent studies concerning congenital nephrotic syndromes and findings in genetically modified mice have demonstrated that podocyte molecules make a pivotal contribution to the maintenance of the selective filtration barrier of the normal glomerulus. However, it is unclear what role podocyte molecules play in proteinuria of acquired renal diseases. This study investigated the mRNA and protein expression of several podocyte-associated molecules in acquired renal diseases. Forty-eight patients with various renal diseases were studied, including minimal change nephropathy, focal segmental glomerulosclerosis, IgA nephropathy, lupus nephritis, and diabetic nephropathy, together with 13 kidneys with normal glomerular function. Protein levels of nephrin, podocin, CD2-associated protein, and podocalyxin were investigated using quantitative immunohistochemical assays. Real-time PCR was used to determine the mRNA levels of nephrin, podocin, and podoplanin in microdissected glomeruli. The obtained molecular data were related to electron microscopic ultrastructural changes, in particular foot process width, and to clinical parameters. In most acquired renal diseases, except in IgA nephropathy, a marked reduction was observed at the protein levels of nephrin, podocin, and podocalyxin, whereas an increase of the glomerular mRNA levels of nephrin, podocin, and podoplanin was found, compared with controls. The mean width of the podocyte foot processes was inversely correlated with the protein levels of nephrin (r = −0.443, P < 0.05), whereas it was positively correlated with podoplanin mRNA levels (r = 0.468, P < 0.05) and proteinuria (r = 0.585, P = 0.001). In the diseases studied, the decrease of slit diaphragm proteins was related to the effacement of foot processes and coincided with a rise of the levels of the corresponding mRNA transcripts. This suggests that the alterations in the expression of podocyte-associated molecules represent a compensatory reaction of the podocyte that results from damage associated with proteinuria. E-mail: k.koop@lumc.nlKeywords
This publication has 32 references indexed in Scilit:
- Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseasesKidney International, 2002
- Changes in the Expression of Nephrin Gene and Protein in Experimental Diabetic NephropathyLaboratory Investigation, 2001
- Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsiesKidney International, 2001
- Frontal Dysfunction and Frontal Cortical Synapse Loss in Alcoholism –The Main Cause of Alcohol Dementia?Dementia and Geriatric Cognitive Disorders, 2001
- Synaptopodin expression in idiopathic nephrotic syndrome of childhoodKidney International, 2001
- Cloning of rat nephrin: Expression in developing glomeruli and in proteinuric statesKidney International, 2000
- Congenital Nephrotic Syndrome in Mice Lacking CD2-Associated ProteinScience, 1999
- Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic SyndromePublished by Elsevier ,1998
- Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell.The Journal of cell biology, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970